A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CTL / cytotoxic T lymphocyte

[Related PubMed/MEDLINE]
Total Number of Papers: 7770
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CTL  (>> Co-occurring Abbreviation)
Long Form:   cytotoxic T lymphocyte
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Adjuvanticity of aqueous extracts of Artemisia rupestris L. for inactivated foot-and-mouth disease vaccine in mice. DCs, FMDV
2019 Age-Associated Heterogeneity of Ty21a-Induced T Cell Responses to HLA-E Restricted Salmonella Typhi Antigen Presentation. CMI, HLA-E, MHC, S. Typhi, TEM
2019 Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes. HPV
2019 Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy. BMDC, HBc NC, OVA-HBc NCs
2019 Cancer Immunotherapy of TLR4 Agonist-Antigen Constructs Enhanced with Pathogen-Mimicking Magnetite Nanoparticles and Checkpoint Blockade of PD-L1. LOS, LPS, MPLA, PD-L1, TLR4
2019 CD4+ T help promotes influenza virus-specific CD8+ T cell memory by limiting metabolic dysfunction. IAVs
2019 CD8+ cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy. OVA
2019 CD8+ Cytotoxic-T-Lymphocyte Breadth Could Facilitate Early Immune Detection of Immunodeficiency Virus-Derived Epitopes with Limited Expression Levels. HIV, MHC-I, SIV
2019 Classification of tumor microenvironment immune types based on immune response-associated gene expression. DC, GEP, HOPE, TME, WES
10  2019 Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions. IL-12, PD-L1
11  2019 Contribution of regulatory T cells to cancer: A review. FOXP3
12  2019 Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein-Barr virus-associated malignancy. EBV, HTL
13  2019 Current concepts of the Pathogenesis of Aplastic Anemia. AA, mDC, NK, pDC, Th, Treg
14  2019 Cytotoxic T-lymphocyte-associated protein 4 expressed by melanoma cells does not affect melanoma-specific cytotoxic T lymphocytes in the effector phase. CTLA-4
15  2019 Ehrlichia ruminantium antigens and peptides induce cytotoxic T cell responses in vitro. FATT, PBMC
16  2019 Ferritin nanoparticle-based SpyTag/SpyCatcher-enabled click vaccine for tumor immunotherapy. ---
17  2019 Generation of Tumor Antigen-Specific Cytotoxic T Lymphocytes from Pluripotent Stem Cells. iPSCs
18  2019 Identification and characterisation of conserved epitopes of E. ruminantium that activate Th1 CD4+ T cells: Towards the development of a multi-epitope vaccine. ELISPOT, GM-CSF, iNOS
19  2019 Identification of novel HLA-A11-restricted T-cell epitopes in the Ebola virus nucleoprotein. EBOV
20  2019 Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses. MAPs
21  2019 Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein-Barr virus (EBV). EBV, HHV-4
22  2019 Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection. ADCC, HCV, ILCs, NK, Treg
23  2019 Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection. CD40L, DHFR, ELISPOT, GM-CSF, HFRS, HTNV, VLPs
24  2019 Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease. APC, GVHD, GVL, HSC
25  2019 Modular core-shell polymeric nanoparticles mimicking viral structures for vaccination. BMDCs, TLR7, VMP, VMPs
26  2019 Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus. NP, rAd
27  2019 Oncolytic Sendai virus-induced tumor-specific immunoresponses suppress "simulated metastasis" of squamous cell carcinoma in an immunocompetent mouse model. FCM, HNSCC, IHC
28  2019 Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo. HPV, ICS, MDSCs
29  2019 SATB family chromatin organizers as master regulators of tumor progression. DC, SATB
30  2019 Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation. CP, ipaH, MEFs, MHC, RP, RPN13, UPS
31  2019 The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice. ---
32  2018 A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice. Chol, DOPE, DSPC, DSPG, Tm
33  2018 A novel MtHSP70-FPR1 fusion protein enhances cytotoxic T lymphocyte responses to cervical cancer cells by activating human monocyte-derived dendritic cells via the p38 MAPK signaling pathway. CC, moDC, MtHSP70-FPR1, PBS
34  2018 A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer. ---
35  2018 Alloreactive cytotoxic T lymphocyte immunotherapy treatment of a patient with metastatic prostate cancer: A case report. ACTL, fPSA, PC, PSA, TURP
36  2018 alphabeta T Cell Receptor Mechanosensing Forces out Serial Engagement. APCs, pMHCs, TCRs
37  2018 An Ad/MVA vectored Theileria parva antigen induces schizont-specific CD8+ central memory T cells and confers partial protection against a lethal challenge. ECF, HAd5, MVA, PBMC
38  2018 An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells. ABD, DCs, iTEP, LNs, MSA
39  2018 An Engineered DC-Targeting Lentivector Induces Robust T Cell Responses and Inhibits HBV Replication in HBV Transgenic Mice via Upregulating T Cell Autophagy. DC, LV, LVs
40  2018 An engineered novel lentivector specifically transducing dendritic cells and eliciting robust HBV-specific CTL response by upregulating autophagy in T cells. DCs
41  2018 An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens. HPV
42  2018 An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. ICI, IRF8, OPN
43  2018 Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer. FADD, HNSCCs, TNF
44  2018 Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice. NK, TCL
45  2018 Antigen-adjuvant effects of icariin in enhancing tumor-specific immunity in mastocytoma-bearing DBA/2J mice. ICA
46  2018 Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival. mCRPC, OS, PAP
47  2018 Antitumoral Potency by Immunomodulation of Chloroform Extract from Leaves of Nitraria retusa, Tunisian Medicinal Plant, via its Major Compounds beta-sitosterol and Palmitic Acid in BALB/c Mice Bearing Induced Tumor. ---
48  2018 B7-H1 maintains the polyclonal T cell response by protecting dendritic cells from cytotoxic T lymphocyte destruction. Ags, DCs
49  2018 Bacillus Calmette-Guerin and anti-PD-L1 combination therapy boosts immune response against bladder cancer. BCa, BCG, MAPK, MDSCs, PD-L1, TLR4
50  2018 Bacterial coinfection restrains antiviral CD8 T-cell response via LPS-induced inhibitory NK cells. LCMV
51  2018 BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma. DC, LCP NPs
52  2018 Cancer Immunoinformatics: A Promising Era in the Development of Peptide Vaccines for Human Papillomavirus-induced Cervical Cancer. HPV, MHC
53  2018 CD8+ Cytotoxic T Lymphocyte Responses and Viral Epitope Escape in Acute HIV-1 Infection. ---
54  2018 Comparison of immunoadjuvant activities of four bursal peptides combined with H9N2 avian influenza virus vaccine. AIV, BF
55  2018 Computational Design of Epitope-Enriched HIV-1 Gag Antigens with Preserved Structure and Function for Induction of Broad CD8+ T Cell Responses. AAS, TeeGag
56  2018 Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines. EBV, Gluc, LMP2, PCR, RT-PCR
57  2018 Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses. HIV-1, SPs, VNPs
58  2018 CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity. CpG 1826, DC, M-M, MBP, MUC1
59  2018 Dendritic Cell-Based Immunotherapy for Solid Tumors. DC, RCC, Treg
60  2018 Dendritic cells loaded with HeLa-derived exosomes simulate an antitumor immune response. CD, DCs, TEM
61  2018 Design of novel multi-epitope vaccines against Severe Acute respiratory syndrome validated through multistage molecular interaction and dynamics. HTL, MEVs, SARS, SARS-CoV
62  2018 Development of a BiTE-mediated CD8+ cytotoxic T-lymphocyte activity assay to assess immunomodulatory potential of drug candidates in Cynomolgus macaque. BiTE, IFN, PBMC
63  2018 Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine. HIV-1, rBCG, rBCG-pMyong2-p24
64  2018 Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design. ELISPOT, HLA, i20S, SLP
65  2018 Direct loading of CTL epitopes onto MHC class I complexes on dendritic cell surface in vivo. ABD, DC, iTEP, LN, sMMP
66  2018 DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors. MVBs
67  2018 Effects of epidermal growth factor receptor fusion protein on the cytotoxic activity of SOCS1-silenced dendritic cells in vitro. DCs, EGFR, FCM, GST, LDH
68  2018 Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy. LDH, TRP-2
69  2018 Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells. ---
70  2018 Evaluation of Cell-Mediated Immune Function Using the Cytotoxic T-Lymphocyte Assay. CMI, MHC
71  2018 Ex Vivo Major Histocompatibility Complex I Knockdown Prolongs Rejection-free Allograft Survival. ECs, MHC-I, qPCR, siMHC-I, VCA
72  2018 Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection. HTL, IFN-gamma
73  2018 Exploring Leptospiral proteomes to identify potential candidates for vaccine design against Leptospirosis using an immunoinformatics approach. HTL, MHC-I
74  2018 Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8+ T Cells. CNS, LCMV, LM
75  2018 Expression, purification, crystallization and preliminary X-ray diffraction analysis of swine leukocyte antigen 2 complexed with a CTL epitope AS64 derived from Asia1 serotype of foot-and-mouth disease virus. FMDV, MHC, SLA-I
76  2018 Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides. WT1
77  2018 Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell Response. CD40L, CML, DCs, iPS-T cells, Th, WT1
78  2018 Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals. ---
79  2018 Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy. APCs, GDMON, TLR9
80  2018 Heat treatment improves the immunomodulatory and cellular antioxidant behavior of a natural flavanone: Eriodictyol. NK, NO
81  2018 Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack. AA, HSCs, iPSCs, WT
82  2018 Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors. HDAC, MM
83  2018 HIV T-Cell Vaccines. ---
84  2018 HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5alpha, leading to the induction of an antiviral state. CA, ECs
85  2018 HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients. mRCC, OS, PFS
86  2018 HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation. ST
87  2018 Host Resistance Assays. NK, TDAR
88  2018 Human CTL-based functional analysis shows the reliability of a munc13-4 protein expression assay for FHL3 diagnosis. FHL, FHL3, HLH
89  2018 Identification of two novel foot-and-mouth disease virus cytotoxic T lymphocyte epitopes that can bind six SLA-I proteins. FMDV, SLA-I
90  2018 IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides. CRC, IgG, OS, RNF43, TOMM34, VEGFR1
91  2018 Immune checkpoint blockade therapy. CTLA-4
92  2018 Immune profiles of desmoplastic small round cell tumor and synovial sarcoma suggest different immunotherapeutic susceptibility upfront compared to relapse specimens. B2M, DSRCT
93  2018 Immune responses against tumour-associated antigen-derived cytotoxic T lymphocyte epitopes in cholangiocarcinoma patients. CEA, ELISPOT, EpCAM, EZH, GPC3, KIF20A, MAGE, MRP, MUC5AC, PCR, SART, TAA
94  2018 Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides. HBcrAg, HBV, IFN, NA
95  2018 Immunization with one Theileria parva strain results in similar level of CTL strain-specificity and protection compared to immunization with the three-component Muguga cocktail in MHC-matched animals. ITM
96  2018 Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma. ICI, MDSC, mUC, PD1, PDL1, PMN
97  2018 In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate. MHC
98  2018 In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics. ANA, anti-dsDNA, anti-RNP, IFN-gamma, IL-17, RORgammat, SLE
99  2018 Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C). CAF, DCs, DDA, DLNs, IM, OVA, s.c
100  2018 Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice. CMI, DAA, ELISPOT, FTA, GT1b, HCV, NS, NS5B, Th